- 작성자 : ILIAS Biologics
- 작성일 : 19-10-08 03:21
- 조회 : 232회
04 Oct 2019
Pharma Intelligence introduced ILIAS Biologics as "Emerging Company"
Emerging Company Profile: South Korea-based ILIAS Biologics aims to establish an exosome therapeutic development pathway using its platform technology EXPLOR, which is said to enable loading large therapeutic proteins into exosomes and stably deliver encapsulated cargo proteins to target cells.